1. Home
  2. SUPV vs AURA Comparison

SUPV vs AURA Comparison

Compare SUPV & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Supervielle S.A. each Representing five Class B shares

SUPV

Grupo Supervielle S.A. each Representing five Class B shares

SELL

Current Price

$7.21

Market Cap

703.9M

Sector

Finance

ML Signal

SELL

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

SELL

Current Price

$6.33

Market Cap

631.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SUPV
AURA
Founded
1887
2007
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
703.9M
631.6M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
SUPV
AURA
Price
$7.21
$6.33
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$11.80
★ $16.60
AVG Volume (30 Days)
539.5K
★ 933.0K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$32.97
N/A
Revenue Next Year
$20.17
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.83
$4.73
52 Week High
$13.55
$9.54

Technical Indicators

Market Signals
Indicator
SUPV
AURA
Relative Strength Index (RSI) 41.62 41.73
Support Level $6.72 $6.03
Resistance Level $7.59 $7.83
Average True Range (ATR) 0.28 0.26
MACD 0.03 0.07
Stochastic Oscillator 57.45 41.33

Price Performance

Historical Comparison
SUPV
AURA

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA a diversified financial services group in Argentina. It offers a broad range of financial products and services including lending, savings and investments, insurance, payments and cash management services, car loans, and asset management, positioning itself as a one-stop destination for financial needs. It operates exclusively in Argentina, through the Bank, which serves as its main banking subsidiary, delivering a comprehensive suite of financial services to retail, SMEs and corporate customers. Its segments include Personal & Business Banking; Corporate Banking; Bank Treasury; Insurance; and Asset Management and Other Services (which includes IOL invertironline). The majority of the revenue is derived from Personal & Business Banking segment.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: